126 related articles for article (PubMed ID: 33155192)
1. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract][Full Text] [Related]
2. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11.
Zhang HP; Chen QK; Xu JF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
[TBL] [Abstract][Full Text] [Related]
3. CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.
Sheng M; Wei N; Yang HY; Yan M; Zhao QX; Jing LJ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7283-7294. PubMed ID: 31539115
[TBL] [Abstract][Full Text] [Related]
4. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
[TBL] [Abstract][Full Text] [Related]
5. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑193a‑5p exerts a tumor suppressive role in epithelial ovarian cancer by modulating RBBP6.
Zhang S; Liu J; He J; Yi N
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132380
[TBL] [Abstract][Full Text] [Related]
7. Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9.
Liu ZH; Liu WJ; Yu XY; Qi XL; Sun CC
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10375-10382. PubMed ID: 33155193
[TBL] [Abstract][Full Text] [Related]
8. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.
Xuan ZH; Wang HP; Zhang XN; Chen ZX; Zhang HY; Gu MM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5259-5266. PubMed ID: 32495859
[TBL] [Abstract][Full Text] [Related]
9. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-196b promotes cell growth and metastasis of ovarian cancer by targeting ZMYND11.
Zhang Z; Xu L; Hu Z; Yang B; Xu J
Minerva Med; 2022 Aug; 113(4):707-717. PubMed ID: 32512976
[TBL] [Abstract][Full Text] [Related]
12. Cervical carcinoma progression is aggravated by lncRNA ZNF281 by binding KLF15.
Hou YM; Wang XP; Shen CC; Chen LT; Zheng XX
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5610-5618. PubMed ID: 34604953
[TBL] [Abstract][Full Text] [Related]
13. MiR-4429 suppresses the malignant development of ovarian cancer by targeting YOD1.
Zhu YM; Chen P; Shi L; Zhu T; Chen X
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8722-8730. PubMed ID: 32964960
[TBL] [Abstract][Full Text] [Related]
14. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
16. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
17. CircRIP2 aggravates the deterioration of colorectal carcinoma by negatively regulating CBFB.
Hou M; Zhang LJ; Liu J; Hu HX; Zhao YL
Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3514-3521. PubMed ID: 35647832
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CDKN2BAS aggravates the progression of ovarian cancer by positively interacting with GAS6.
Wang HM; Shen SL; Li NM; Su HF; Li WY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5946-5952. PubMed ID: 32572907
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.
Yang N; Zhang Q; Bi XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):65-73. PubMed ID: 31957819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
